Dynamic thermal simulation of advanced natural ventilation in buildings : current and future usage, UK exemplar

This paper evaluates the use of advanced natural ventilation (ANV) strategies in a range of climatic conditions from four cities in the UK. A prototype ANV system was proposed to determine the most effective case in mitigating overheating. The case was then assessed under identical simulation conditions for all four ANV strategies. The overheating criteria used in the research include the single temperature criterion from CIBSE Guide A and the adaptive thermal comfort overheating criteria from BS EN 15251. Both the current and future ‘Design Summer Year (DSY)’ weather data were used to examine the thermal performances of the proposed design. The findings show that shading, night cooling and heavy weight structures (ceiling) were all useful in mitigating overheating, with night cooling being identified as the most effective measure. The work assessed the use of ANV in both current and future scenarios to quantify the limits of outdoor environmental conditions under which natural ventilation is an effective strategy for achieving thermal comfort. The adaptive thermal comfort overheating criteria were proved to be easier to meet compared with the CIBSE single temperature criterion. With the adaptive overheating criteria, the given design is predicted to not overheat until 2050 in London Heathrow; and for other places evaluated in the UK (Edinburgh, Manchester & Birmingham), the design passes these criteria. The Centre-in ANV strategies proved to be more effective than the Edge-in strategies for space cooling due to the extended structure thermal mass

A spectroscopic study of the structure of amorphous hydrogenated carbon

A range of amorphous hydrogenated carbon (a-C:H) samples have been studied using inelastic neutron spectroscopy (INS) and Fourier transform infrared (FTIR) spectroscopy. Using these complementary techniques, the bonding environments of both carbon and hydrogen can be probed in some detail, with the INS data providing not only qualitative but also quantitative information. By comparing the data from each of the samples we have been able to examine the effects of different deposition conditions, i.e. precursor gas, deposition energy and deposition method, on the atomic-scale structure of a-C:H

Indoor Air Quality (IAQ) in Naturally-ventilated Primary Schools in the UK:Occupant-Related Factors

Indoor Air Quality (IAQ) is affected by Context, Occupant and Building (COB) related factors. This paper evaluates IAQ as a function of occupant-related factors including occupants' Adaptive Behaviours (ABs), occupancy patterns, occupant's CO2 generation rates and occupancy density. This study observed occupant-related factors of 805 children in 29 naturally-ventilated (NV) classrooms in UK primary schools during Non-Heating and Heating seasons. Occupant-related factors affecting IAQ include occupants' adaptive behaviours, occupancy patterns, occupants' CO2 generation rate and occupancy densities. Results of this study suggest that a classroom with high potentials for natural ventilation does not necessarily provide adequate IAQ, however, occupants’ good practice of ABs is also required. Average occupancy densities to have CO2 levels of 1000 ± 50 ppm are suggested to be 2.3 ± 0.05m2/p and 7.6 ± 0.25 m3/p. These values correspond to the classroom area of 62.1 ± 1.35 m2 and volume of 205.2 ± 6.75 m3 with a height of 3.3 m. Mean CO2 level is maintained below 900 ppm when all occupant-related factors are in the favour of IAQ, however, it exceeds 1300 ppm when none of the occupant-related factors are in favour of IAQ. It is shown that 17% of CO2 variations are explained by open area (m2), 14% by occupants' generation rates (cm3/s) and 11% by occupancy density (m3/p). IAQ is mostly affected by occupants’ adaptive behaviours than other occupant-related factors in naturally-ventilated classrooms

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

<p>Abstract</p> <p>Background</p> <p>High antibiotic resistance is described in atypical Mycobacteriosis, mainly by <it>Mycobacterium avium </it>complex (MAC).</p> <p>Methods</p> <p>A randomized, double-blind, placebo-controlled clinical trial was carried out in two hospitals to evaluate the effect of interferon (IFN) gamma as immunoadjuvant to chemotherapy on patients with atypical mycobacteria lung disease. Patients received placebo or 1 × 10⁶IU recombinant human IFN gamma intramuscularly, daily for one month and then three times per week up to 6 months as adjuvant to daily oral azithromycin, ciprofloxacin, ethambutol and rifampin. Sputum samples collection for direct smear observation and culture as well as clinical and thorax radiography assessments were done during treatment and one year after. Cytokines and oxidative stress determinations were carried out in peripheral blood before and after treatment.</p> <p>Results</p> <p>Eighteen patients were included in the IFN group and 14 received placebo. Groups were homogeneous at entry; average age was 60 years, 75% men, 84% white; MAC infection prevailed (94%). At the end of treatment, 72% of patients treated with IFN gamma were evaluated as complete responders, but only 36% in the placebo group. The difference was maintained during follow-up. A more rapid complete response was obtained in the IFN group (5 months before), with a significantly earlier improvement in respiratory symptoms and pulmonary lesions reduction. Disease-related deaths were 35.7% of the patients in the placebo group and only 11.1% in the IFN group. Three patients in the IFN group normalized their globular sedimentation rate values. Although differences in bacteriology were not significant during the treatment period, some patients in the placebo group converted again to positive during follow-up. Significant increments in serum TGF-beta and advanced oxidation protein products were observed in the placebo group but not among IFN receiving patients. Treatments were well tolerated. Flu-like symptoms predominated in the IFN gamma group. No severe events were recorded.</p> <p>Conclusion</p> <p>These data suggest that IFN gamma is useful and well tolerated as adjuvant therapy in patients with pulmonary atypical Mycobacteriosis, predominantly MAC. Further wider clinical trials are encouraged.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN70900209.</p

Society of American Foresters (1980) E-1 Appendix E: Existing Vegetation References and Codes

SAF 235 Cottonwood- willow SAF 237 Interior ponderosa pine SAF 239 Pinyon- juniper SAF 240 Arizona cypress SAF 241 Western live oak SAF 242 Mesquit